1.0MedCity INVEST PharmaTechhttps://events.medcitynews.com/invest-pharmatechLaura Kittredgehttps://events.medcitynews.com/invest-pharmatech/author/lkittredge/Sharon Hanlon, MSN - MedCity INVEST PharmaTechrich600338<blockquote class="wp-embedded-content" data-secret="T829tbKUK3"><a href="https://events.medcitynews.com/invest-pharmatech/speakers/%e2%80%8bsharon-hanlon/">Sharon Hanlon, MSN</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://events.medcitynews.com/invest-pharmatech/speakers/%e2%80%8bsharon-hanlon/embed/#?secret=T829tbKUK3" width="600" height="338" title="“Sharon Hanlon, MSN” — MedCity INVEST PharmaTech" data-secret="T829tbKUK3" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://events.medcitynews.com/invest-pharmatech/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://events.medcitynews.com/uploads/sites/3/2022/05/Sharon-Hanlon-Headshot-e1653585067433.jpg16771700Sharon Hanlon is Senior Director, Clinical Trial Engagement & Enrollment at Bristol-Myers Squibb (BMS). Sharon and her team partner with patients, caregivers, patient advocacy groups and clinical trial sites to gather insights which, when applied to clinical trial development and recruitment efforts, create a more patient- and site-friendly experience. Additionally, Sharon and her team are…